Cargando…

JMJD3 in the regulation of human diseases

In recent years, many studies have shown that histone methylation plays an important role in maintaining the active and silent state of gene expression in human diseases. The Jumonji domain-containing protein D3 (JMJD3), specifically demethylate di- and trimethyl-lysine 27 on histone H3 (H3K27me2/3)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiangxian, Liu, Li, Yuan, Xia, Wei, Yuquan, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881266/ https://www.ncbi.nlm.nih.gov/pubmed/31701394 http://dx.doi.org/10.1007/s13238-019-0653-9

Ejemplares similares

Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials
por: Yuan, Xia, et al.
Publicado: (2019)

JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis
por: Chen, Siyuan, et al.
Publicado: (2023)

The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022)

Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway
por: Liu, Yu, et al.
Publicado: (2022)

Mitochondrial DNA in the regulation of innate immune responses
por: Fang, Chunju, et al.
Publicado: (2015)

Coronavirus in human diseases: Mechanisms and advances in clinical treatment
por: Lin, Panpan, et al.
Publicado: (2020)

CCL5/CCR5 axis in human diseases and related treatments
por: Zeng, Zhen, et al.
Publicado: (2021)

The Functions of the Demethylase JMJD3 in Cancer
por: Sanchez, Anna, et al.
Publicado: (2021)

JMJD3: a critical epigenetic regulator in stem cell fate
por: Ding, Yuanjie, et al.
Publicado: (2021)

Histone demethylase JMJD2C: epigenetic regulators in tumors
por: Zhang, Chengcheng, et al.
Publicado: (2017)

The Memory of Environmental Chemical Exposure in C. elegans Is Dependent on the Jumonji Demethylases jmjd-2 and jmjd-3/utx-1
por: Camacho, Jessica, et al.
Publicado: (2018)

Epigenetic regulation of macrophages: from homeostasis maintenance to host defense
por: Chen, Siyuan, et al.
Publicado: (2019)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023)

JMJD5 is a human arginyl C-3 hydroxylase
por: Wilkins, Sarah E., et al.
Publicado: (2018)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

Molecular mechanisms and clinical management of cancer bone metastasis
por: Wang, Manni, et al.
Publicado: (2020)

JMJD3 and UTX determine fidelity and lineage specification of human neural progenitor cells
por: Shan, Yongli, et al.
Publicado: (2020)

Critical role of histone demethylase Jmjd3 in the regulation of CD4(+) T cell differentiation
por: Li, Qingtian, et al.
Publicado: (2014)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
por: Zhu, Chenjing, et al.
Publicado: (2019)

Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7
por: Liu, Haolin, et al.
Publicado: (2018)

Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
por: Wei, Xiawei, et al.
Publicado: (2019)

Role of lysosomes in physiological activities, diseases, and therapy
por: Zhang, Ziqi, et al.
Publicado: (2021)

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
por: Xu, Maosen, et al.
Publicado: (2021)

The Roles of Histone Demethylase Jmjd3 in Osteoblast Differentiation and Apoptosis
por: Yang, Di, et al.
Publicado: (2017)

Induction of neutrophil extracellular traps during tissue injury: Involvement of STING and Toll‐like receptor 9 pathways
por: Liu, Li, et al.
Publicado: (2019)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis
por: Li, Lu, et al.
Publicado: (2020)

Role of tumor gene mutations in treatment response to immune checkpoint blockades
por: Wang, Manni, et al.
Publicado: (2019)

Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development
por: Hong, Qiaonan, et al.
Publicado: (2023)

JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC
por: Li, Shu-Man, et al.
Publicado: (2020)

Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases
por: Fu, Minyang, et al.
Publicado: (2022)

Global gene expression profiling of JMJD6- and JMJD4-depleted mouse NIH3T3 fibroblasts
por: Hu, Yu-Jie, et al.
Publicado: (2016)

Publisher Correction: JMJD5 is a human arginyl C-3 hydroxylase
por: Wilkins, Sarah E., et al.
Publicado: (2018)

Targeting PI3K in cancer: mechanisms and advances in clinical trials
por: Yang, Jing, et al.
Publicado: (2019)

Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
por: Zheng, Heng, et al.
Publicado: (2019)

Involvement of inflammasomes in tumor microenvironment and tumor therapies
por: Zhang, Ziqi, et al.
Publicado: (2023)

JMJD family proteins in cancer and inflammation
por: Manni, Wang, et al.
Publicado: (2022)

Ikaros Proteins in Tumor: Current Perspectives and New Developments
por: Xia, Ruolan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uiv2u0jheb0cetp9lg94hjuh46